Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Primary Ovarian Insufficiency or Menopause, Premature
and you are
between 18 and 40
years old
The phase for this study is not defined.
Show me locations

The purpose

Premature ovarian insufficiency (POI) is a life-changing condition that affects women in their reproductive age. There is a lack of reports which focus on how to improve the reproductive outcome of these women who wish to conceive spontaneously or use assisted conception with their own oocytes. However, one could surmise that it is important to lower gonadotropin levels into the physiological range before embarking on any treatment, even if natural conception is the only choice for the woman/couple.

Provided treatments

  • Drug: Drospirenone and ethinyl estradiol combination (Yasmin)
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02757469. The sponsor of the trial is Navy General Hospital, Beijing and it is looking for 20 volunteers for the current phase.
Official trial title:
Drospirenone and Ethinyl Estradiol Combinations (Yasmin) as Infertility Treatments for Premature Ovarian Failure: a Perspective Follow-up Study.